Aberrations involving MYC, in terms of both gains of 8q24 or translocations t(8; 14) (q24; q32), are a common event of hBCL and are associated with a more aggressive phenotype and poor outcome in human DLBCL, including shorter progression-free interval and overall survival [29]. This evidence concerns the gene MYC and diffuse large B-cell lymphoma.